These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 36760069)
1. The possibility of visualizing TGF-β1 expression in ApoE Xia M; Wu F; Yang Y; Lu W; Song M; Ma Z Acta Radiol; 2024 Jan; 65(1):99-105. PubMed ID: 36760069 [TBL] [Abstract][Full Text] [Related]
2. In vivo MRI detection of atherosclerosis in ApoE-deficient mice by using tenascin-C-targeted USPIO. Li Y; Liu J; Huang JW; Song JC; Ma ZL; Shi HB Acta Radiol; 2018 Dec; 59(12):1431-1437. PubMed ID: 29566551 [TBL] [Abstract][Full Text] [Related]
3. [Feasibility of targeted magnetic resonance imaging on visualizing tenascin-C expression in atherosclerosis plaque in high-fat diet fed ApoE(-/-) mice]. Meng H; Ma ZL; Yan HL; Chen XX; Shang SA; Yu J; Song JC; Shi HB Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):342-7. PubMed ID: 27112614 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378 [TBL] [Abstract][Full Text] [Related]
5. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067 [TBL] [Abstract][Full Text] [Related]
6. In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles. Wen S; Liu DF; Cui Y; Harris SS; Chen YC; Li KC; Ju SH; Teng GJ Nanomedicine; 2014 Apr; 10(3):639-49. PubMed ID: 24103305 [TBL] [Abstract][Full Text] [Related]
7. T1-weighted MRI of targeting atherosclerotic plaque based on CD40 expression on engulfed USPIO's cell surface. Huang C; Huang W; Meng Y; Zhou C; Wang X; Zhang C; Tian Y; Wei W; Li Y; Zhou Q; Chen W; Tang Y Biomed Mater; 2024 Jan; 19(2):. PubMed ID: 38215489 [TBL] [Abstract][Full Text] [Related]
8. Dual-modality imaging of atherosclerotic plaques using ultrasmall superparamagnetic iron oxide labeled with rhodamine. Li Y; Pan Y; Wu X; Li Y; Wang H; Zhu H; Jiang L Nanomedicine (Lond); 2019 Aug; 14(15):1935-1944. PubMed ID: 31355711 [No Abstract] [Full Text] [Related]
11. Detection of Vulnerable Atherosclerotic Plaques in Experimental Atherosclerosis with the USPIO-Enhanced MRI. Qi CM; Du L; Wu WH; Li DY; Hao J; Gong L; Deng L; Zhang T; Zhang C; Zhang Y Cell Biochem Biophys; 2015 Nov; 73(2):331-337. PubMed ID: 27352319 [TBL] [Abstract][Full Text] [Related]
12. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions. Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990 [TBL] [Abstract][Full Text] [Related]
13. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588 [TBL] [Abstract][Full Text] [Related]
14. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin. Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795 [TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment. Hu ZP; Fang XL; Sheng B; Guo Y; Yu YQ Vascul Pharmacol; 2020 Apr; 127():106659. PubMed ID: 32068091 [TBL] [Abstract][Full Text] [Related]
16. Changes in CD4 Xue-Mei L; Jie C; Xuan D; Xiao-Xing L; Chun-Lin H; Yu-Jie L Exp Biol Med (Maywood); 2017 May; 242(9):918-925. PubMed ID: 28114815 [TBL] [Abstract][Full Text] [Related]
17. Anti-connective tissue growth factor detects and reduces plaque inflammation in early-stage carotid atherosclerotic lesions. Yao Y; Li B; Fu C; Teng G; Ma G; Liu N Nanomedicine; 2017 Nov; 13(8):2385-2394. PubMed ID: 28782610 [TBL] [Abstract][Full Text] [Related]
18. Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages. Cheng D; Li X; Zhang C; Tan H; Wang C; Pang L; Shi H ACS Appl Mater Interfaces; 2015 Feb; 7(4):2847-55. PubMed ID: 25569777 [TBL] [Abstract][Full Text] [Related]
19. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques. Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196 [TBL] [Abstract][Full Text] [Related]
20. Experimental Study of Ultrafine Superparamagnetic Iron Oxide-Enhanced MRI in an Atherosclerotic Plaque Model. Chen X; Li X; Chen Q J Nanosci Nanotechnol; 2020 Dec; 20(12):7444-7450. PubMed ID: 32711613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]